Cargando…

Impact of ERK5 on the Hallmarks of Cancer

Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Stecca, Barbara, Rovida, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471124/
https://www.ncbi.nlm.nih.gov/pubmed/30901834
http://dx.doi.org/10.3390/ijms20061426
_version_ 1783411956440367104
author Stecca, Barbara
Rovida, Elisabetta
author_facet Stecca, Barbara
Rovida, Elisabetta
author_sort Stecca, Barbara
collection PubMed
description Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting.
format Online
Article
Text
id pubmed-6471124
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64711242019-04-26 Impact of ERK5 on the Hallmarks of Cancer Stecca, Barbara Rovida, Elisabetta Int J Mol Sci Review Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting. MDPI 2019-03-21 /pmc/articles/PMC6471124/ /pubmed/30901834 http://dx.doi.org/10.3390/ijms20061426 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stecca, Barbara
Rovida, Elisabetta
Impact of ERK5 on the Hallmarks of Cancer
title Impact of ERK5 on the Hallmarks of Cancer
title_full Impact of ERK5 on the Hallmarks of Cancer
title_fullStr Impact of ERK5 on the Hallmarks of Cancer
title_full_unstemmed Impact of ERK5 on the Hallmarks of Cancer
title_short Impact of ERK5 on the Hallmarks of Cancer
title_sort impact of erk5 on the hallmarks of cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471124/
https://www.ncbi.nlm.nih.gov/pubmed/30901834
http://dx.doi.org/10.3390/ijms20061426
work_keys_str_mv AT steccabarbara impactoferk5onthehallmarksofcancer
AT rovidaelisabetta impactoferk5onthehallmarksofcancer